Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SIGLEC9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
SIGLEC7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
SIGLEC17P - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KLK14 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KLK13 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CD33 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KLK12 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KLK11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KLK10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SIGLECL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IGLON5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
VSIG10L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ETFB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on